-Aryl-3-mercaptosuccinimides as Antivirulence Agents Targeting Elastase and Collagenases.

In light of the global antimicrobial-resistance crisis, there is an urgent need for novel bacterial targets and antibiotics with novel modes of action. It has been shown that elastase (LasB) and () collagenase (ColH) play a significant role in the infection process and thereby represent promising antivirulence targets. Here, we report novel -aryl-3-mercaptosuccinimide inhibitors that target both LasB and ColH, displaying potent activities and high selectivity for the bacterial over human metalloproteases. Additionally, the inhibitors demonstrate no signs of cytotoxicity against selected human cell lines and in a zebrafish embryo toxicity model. Furthermore, the most active ColH inhibitor shows a significant reduction of collagen degradation in an pig-skin model.